ANIK Stock Analysis: Buy, Sell, or Hold?
ANIK - Anika Therapeutics Inc
$21.50
0.33 (1.56%)
▲
5d:
+0.37%
30d:
+35.9%
90d:
+40.16%
WAIT
LOW Confidence
Analysis Updated: Aug 14, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Get Alerted When ANIK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ANIK shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ANIK shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$20.53
Based on -2.7% avg growth
INTRINSIC VALUE TODAY
$12.75
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ANIK is currently trading at $21.50, which is considered extended relative to its 30-day fair value range of $14.97 to $20.09. From a valuation perspective, the stock is trading at a discount (Forward PE: 22.6) compared to its historical average (35.0). Remarkably, the market is currently pricing in an annual earnings decline of 13.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ANIK is in a uptrend. Immediate support is located at $18.98, while resistance sits at $22.88.
Market Sentiment: ANIK scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ANIK is in a uptrend. Immediate support is located at $18.98, while resistance sits at $22.88.
Market Sentiment: ANIK scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$14.97 -
$20.09
Company Quality Score
29/100
(SELL)
Options IV Signal
31th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
28.8%
Protect Your Profits
Holding ANIK? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+7.0% above its trading range)
- NEUTRAL: Options fairly priced (IV 31th percentile)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($21.00)
- WARNING: Composite score 29/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$14.97 -
$20.09
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$2.70
(12.6%)
Support & Resistance Levels
Support Level
$18.98
Resistance Level
$22.88
Current Trend
Uptrend
Technical data as of
Aug 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.63
Wall Street Target
$21.00
(-2.3%)
Revenue Growth (YoY)
15.6%
Earnings Growth (YoY)
-50.5%
Profit Margin
-3.1%
Valuation Discount vs History
-13.5% cheaper
PE vs Historical
22.6 vs 35.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.5%
(market-implied from PE analysis)
1-Year Target
$19.35
(-10%)
2-Year Target
$17.41
(-19%)
3-Year Target
$15.67
(-27%)
3-Yr Target (if PE normalizes)
(PE: 23→35)
$24.24
(+13%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.6, Growth: -9.5%)
$15.92
(+-26%)
Base:
(SPY PE: 20.2, Growth: -9.5%)
$14.23
(-34%)
Bear:
(PE: 17.2, Growth: -9.5%)
$12.10
(-44%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 22.6 to 35.0
Stabilization Target:
$33.25
(+54.7%)
PE Expansion Potential:
+54.7%
Share & Embed Analysis
Last updated: August 15, 2026 7:41 AM ET
Data refreshes hourly during market hours. Next update: 8:41 AM
Data refreshes hourly during market hours. Next update: 8:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ANIK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$213 | 61 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$107 | 56 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$108 | 44 HOLD |
|
INDV
Indivior PLC Ordinary Sh… |
STRONG BUY
7 analysts |
$49 | 69 BUY |
|
ALKS
Alkermes Plc |
BUY
15 analysts |
$56 | 68 BUY |
Advanced ANIK Option Strategies
Professional options setups generated by AI based on today's ANIK price and gamma walls.
